Skip to main content

Arrayit Opens New Diagnostics Marketing Division

NEW YORK (GenomeWeb News) – Sunnyvale, Calif.-based Arrayit is opening a business based in Houston that will serve as a commercial arm for diagnostics that will run on the company's microarray platform.

The Arrayit Diagnostics subsidiary will promote and market tests using the microarray platform that are aimed at early-stage diagnostics. Arrayit currently is developing diagnostic tests for cancer, neurodegenerative disease, and other diseases.

The company said that Arrayit Diagnostics will launch an "intensive" marketing campaign supported by a network of 41 international life science and diagnostic distributors in 38 countries.

The Scan

Call to Look Again

More than a dozen researchers penned a letter in Science saying a previous investigation into the origin of SARS-CoV-2 did not give theories equal consideration.

Not Always Trusted

In a new poll, slightly more than half of US adults have a great deal or quite a lot of trust in the Centers for Disease Control and Prevention, the Hill reports.

Identified Decades Later

A genetic genealogy approach has identified "Christy Crystal Creek," the New York Times reports.

Science Papers Report on Splicing Enhancer, Point of Care Test for Sexual Transmitted Disease

In Science this week: a novel RNA structural element that acts as a splicing enhancer, and more.